We are live on ! Find out more
HSCS icon

HeartSciences

2.08 USD
-0.05
2.35%
At close Updated Nov 16, 4:00 PM EST
Pre-market
After hours
2.15
+0.07
3.37%
1 day
-2.35%
5 days
-23.53%
1 month
-31.13%
3 months
-5.88%
6 months
11.83%
Year to date
-33.76%
1 year
-30.67%
5 years
-98.78%
10 years
-98.78%
 

About: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

Employees: 14

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 12.5%
Neutral 75%
Negative 12.5%
Neutral
GlobeNewsWire
23 hours ago
Fortitude Reports Financial and Operating Results for the Nine Months Ended September 30, 2026
Company generated $57.9 million in revenue and Adjusted EBITDA of $17.1 million during the nine-month period ended September 30, 2026
Fortitude Reports Financial and Operating Results for the Nine Months Ended September 30, 2026
Positive
Zacks Investment Research
25 days ago
Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?
Here is how HeartSciences Inc. (HSCS) and ImmunityBio (IBRX) have performed compared to their sector so far this year.
Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?
Neutral
GlobeNewsWire
26 days ago
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Definitive proxy statement filed with the SEC, marking an important milestone toward completion of the proposed transaction HeartSciences Board of Directors unanimously recommends shareholders vote FOR the transaction-related proposals Proposed combination expected to establish a publicly traded, vertically-integrated digital asset mining platform focused on Zcash, subject to shareholder approval and other closing conditions SOUTHLAKE, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an AI-powered medical technology company, today announced that it has filed its definitive proxy statement on Schedule 14A (the "Definitive Proxy Statement") with the U.S. Securities and Exchange Commission ("SEC") in connection with its previously announced proposed business combination with Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash (the "Proposed Transaction"). The filing of the Definitive Proxy Statement represents an important milestone toward completing the Proposed Transaction, which was initially announced on June 23, 2026.
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Neutral
GlobeNewsWire
1 month ago
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) for its MyoVista® wavECGTM device as a 12-lead resting electrocardiograph. The clearance covers the acquisition and interpretation of ECG signals from adult and pediatric patients in hospitals and healthcare facilities, with interpretive statements provided to clinicians on an advisory basis.
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Neutral
Business Wire
1 month ago
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. (“Fortitude” or the “Company”), a vertically-integrated digital asset mining platform anchored in Zcash, today announced the appointment of Kimberly Pittman as Chief Legal Officer, effective September 28. Pittman joins Fortitude's executive leadership team as the Company prepares for its previously announced proposed business combination with HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences”). In her role, Pittman will work along.
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
Neutral
GlobeNewsWire
2 months ago
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Negative
Zacks Investment Research
2 months ago
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
HeartSciences Inc. (HSCS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $1.58 per share a year ago.
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
Neutral
GlobeNewsWire
2 months ago
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase date The exchange ratio under the merger agreement with Fortitude is unchanged, and no additional shares will be issued to holders of Fortitude's equity interests at closing as a result of the investment Following the investment, Fortitude holds approximately 9.4% of HeartSciences' outstanding shares of common stock Southlake, TX, Aug. 19, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that on August 12, 2026 Fortitude Mining Holdings, Inc. (“Fortitude”) purchased 411,522 shares of HeartSciences' common stock for an aggregate purchase price of approximately $1,000,000 in a private placement (the “Investment”). The shares were issued at a negotiated price of $2.43 per share, representing a 22% premium to the closing price of HeartSciences' common stock on the purchase date.
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Neutral
GlobeNewsWire
3 months ago
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch of the MyoVista Insights platform and submission of the MyoVista wavECG device to the FDA for 510(k) clearance
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Neutral
GlobeNewsWire
3 months ago
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be filed shortly, with fiscal 2026 earnings release and business update to follow Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be filed shortly, with fiscal 2026 earnings release and business update to follow
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Price charts implemented using Lightweight Charts™